Home Other Building Blocks 344458-19-1
344458-19-1,MFCD17014689
Catalog No.:AA007FG1

344458-19-1 | PJ34

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$122.00   $85.00
- +
10mg
≥98%
in stock  
$163.00   $114.00
- +
25mg
≥98%
in stock  
$295.00   $207.00
- +
50mg
≥98%
in stock  
$375.00   $263.00
- +
100mg
≥98%
in stock  
$566.00   $397.00
- +
250mg
≥98%
in stock  
$1,204.00   $843.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA007FG1
Chemical Name:
PJ34
CAS Number:
344458-19-1
Molecular Formula:
C17H17N3O2
Molecular Weight:
295.3358
MDL Number:
MFCD17014689
SMILES:
CN(CC(=O)Nc1ccc2c(c1)c1ccccc1c(=O)[nH]2)C
Properties
Computed Properties
 
Complexity:
438  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
3  
XLogP3:
1.7  

Literature

Title: 17-beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha.

Journal: Toxicology letters 20150105

Title: A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.

Journal: Cell metabolism 20141104

Title: Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation.

Journal: Neuroscience 20140131

Title: Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake.

Journal: Neuropharmacology 20120901

Title: Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.

Journal: British journal of pharmacology 20120801

Title: Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells.

Journal: Anti-cancer drugs 20120701

Title: Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance.

Journal: The European journal of neuroscience 20120701

Title: Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors.

Journal: European journal of medicinal chemistry 20120401

Title: Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.

Journal: Acta crystallographica. Section F, Structural biology and crystallization communications 20120201

Title: Chromatin composition is changed by poly(ADP-ribosyl)ation during chromatin immunoprecipitation.

Journal: PloS one 20120101

Title: Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus.

Journal: Nephron. Experimental nephrology 20120101

Title: Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.

Journal: Molecular cancer 20120101

Title: Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway.

Journal: Stem cells (Dayton, Ohio) 20111201

Title: Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).

Journal: Atherosclerosis 20111101

Title: Inhibition of poly(ADP-ribose) polymerase (PARP) induces apoptosis in lung cancer cell lines.

Journal: Cancer investigation 20111101

Title: Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.

Journal: Oncogene 20111020

Title: The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest.

Journal: DNA repair 20111010

Title: SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells.

Journal: Cell cycle (Georgetown, Tex.) 20110915

Title: PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1.

Journal: Biochemical and biophysical research communications 20110826

Title: PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20110701

Title: Studies of locomotor network neuroprotection by the selective poly(ADP-ribose) polymerase-1 inhibitor PJ-34 against excitotoxic injury to the rat spinal cord in vitro.

Journal: The European journal of neuroscience 20110601

Title: Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.

Journal: Biology of reproduction 20110501

Title: N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.

Journal: Neuro-oncology 20110501

Title: p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.

Journal: Neoplasia (New York, N.Y.) 20110501

Title: 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).

Journal: Journal of medicinal chemistry 20110414

Title: Effect of the PARP-1 inhibitor PJ 34 on excitotoxic damage evoked by kainate on rat spinal cord organotypic slices.

Journal: Cellular and molecular neurobiology 20110401

Title: Poly(ADP-ribose) polymerase 1 is involved in glucose toxicity through SIRT1 modulation in HepG2 hepatocytes.

Journal: Journal of cellular biochemistry 20110101

Title: A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells.

Journal: BMC cancer 20110101

Title: Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell.

Journal: PloS one 20110101

Title: Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation.

Journal: Free radical biology & medicine 20101215

Title: Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme.

Journal: Bioorganic & medicinal chemistry 20101115

Title: Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia.

Journal: Cancer research 20100715

Title: The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.

Journal: Brain research 20100709

Title: Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.

Journal: Surgery 20100701

Title: [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage].

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20100701

Title: Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.

Journal: Journal of cellular physiology 20100201

Title: Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?

Journal: Critical care (London, England) 20100101

Title: Inhibition of matrix metalloproteinase-2 by PARP inhibitors.

Journal: Biochemical and biophysical research communications 20091002

Title: PolyADP-ribosylation is required for long-term memory formation in mammals.

Journal: Journal of neurochemistry 20091001

Title: Aldosterone-induced endothelial dysfunction of rat aorta: role of poly(ADP-ribose) activation.

Journal: Journal of the renin-angiotensin-aldosterone system : JRAAS 20090901

Title: Poly-(ADP-ribose) polymerase-1 is necessary for long-term facilitation in Aplysia.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20090729

Title: A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targeting.

Journal: Cellular and molecular neurobiology 20090701

Title: Nitric oxide and superoxide anion differentially activate poly(ADP-ribose) polymerase-1 and Bax to induce nuclear translocation of apoptosis-inducing factor and mitochondrial release of cytochrome c after spinal cord injury.

Journal: Journal of neurotrauma 20090701

Title: Roles of inhibitors of poly(ADP-ribose) polymerase in protecting rat RINm5F cell line against free fatty acid-induced apoptosis.

Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20090601

Title: Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.

Journal: Haematologica 20090501

Title: Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20090401

Title: Selective blockade of CaMKII-alpha inhibits NMDA-induced caspase-3-dependent cell death but does not arrest PARP-1 activation or loss of plasma membrane selectivity in rat retinal neurons.

Journal: Brain research 20090223

Title: Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors.

Journal: Journal of medicinal chemistry 20090212

Title: PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts.

Journal: Cardiovascular research 20090101

Title: Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury.

Journal: Vascular and endovascular surgery 20090101

Title: Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB.

Journal: Mediators of inflammation 20090101

Title: Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells.

Journal: Oncogene 20081016

Title: Sulfasalazine blocks the development of tactile allodynia in diabetic rats.

Journal: Diabetes 20081001

Title: PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.

Journal: Oncology reports 20080901

Title: Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation.

Journal: Journal of neurochemistry 20080701

Title: Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34.

Journal: International journal of molecular medicine 20080701

Title: Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.

Journal: European journal of pharmacology 20080624

Title: [Methods of increasing ischemic tolerance in liver surgery].

Journal: Magyar sebeszet 20080601

Title: Zinc triggers microglial activation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080528

Title: PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.

Journal: Basic & clinical pharmacology & toxicology 20080501

Title: PARP1 is required for adhesion molecule expression in atherogenesis.

Journal: Cardiovascular research 20080401

Title: PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.

Journal: Arteriosclerosis, thrombosis, and vascular biology 20080401

Title: Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.

Journal: Critical care medicine 20080201

Title: Poly (ADP-ribose) polymerase as a potential target for the treatment of acute renal injury caused by lipopolysaccharide.

Journal: Renal failure 20080101

Title: Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression.

Journal: European journal of pharmacology 20071114

Title: Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.

Journal: International journal of molecular medicine 20071101

Title: Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells.

Journal: The Journal of nutrition 20071001

Title: Poly(ADP-ribose) polymerase-1 is involved in the neuronal death induced by quinolinic acid in rats.

Journal: Neuroscience letters 20070920

Title: Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.

Journal: The Journal of surgical research 20070901

Title: Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.

Journal: British journal of pharmacology 20070801

Title: Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070701

Title: Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models.

Journal: Biochemical and biophysical research communications 20070608

Title: The role of poly(ADP-ribose) polymerase (PARP) in the autonomous proliferative response of endothelial cells to hypoxia.

Journal: Cardiovascular research 20070201

Title: Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.

Journal: Stroke 20070201

Title: Homocysteine-induced changes in vascular reactivity of guinea-pig pulmonary arteries: role of the oxidative stress and poly (ADP-ribose) polymerase activation.

Journal: Pulmonary pharmacology & therapeutics 20070101

Title: Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase.

Journal: Microvascular research 20070101

Title: Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells.

Journal: Clinical and experimental immunology 20070101

Title: Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts.

Journal: Cellular and molecular life sciences : CMLS 20061201

Title: Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis.

Journal: Biochemical and biophysical research communications 20061117

Title: Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.

Journal: Diabetes 20061101

Title: Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.

Journal: The Journal of surgical research 20061001

Title: Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.

Journal: British journal of pharmacology 20060901

Title: Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.

Journal: Journal of neurochemistry 20060901

Title: Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.

Journal: Journal of the American College of Surgeons 20060701

Title: Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20060615

Title: MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic beta-cells.

Journal: Diabetes 20060301

Title: Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor.

Journal: The Journal of surgical research 20051201

Title: 4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20051001

Title: Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.

Journal: Laboratory investigation; a journal of technical methods and pathology 20051001

Title: Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy.

Journal: Trends in molecular medicine 20051001

Title: Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells.

Journal: Molecular pharmacology 20050901

Title: PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.

Journal: Surgery 20050801

Title: Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis.

Journal: Nuclear medicine and biology 20050701

Title: Poly(ADP-ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest.

Journal: American journal of physiology. Heart and circulatory physiology 20050601

Title: Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta.

Journal: Pharmacological research 20050601

Title: Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat.

Journal: Brain research 20050418

Title: Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.

Journal: Archives of surgery (Chicago, Ill. : 1960) 20050401

Title: Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure.

Journal: Biochemical pharmacology 20050301

Title: Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.

Journal: The Biochemical journal 20050201

Title: Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.

Journal: Journal of vascular surgery 20050101

Title: Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.

Journal: Stroke 20041201

Title: Poly(ADP-ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta.

Journal: Pharmacology 20041001

Title: The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.

Journal: The Journal of pharmacology and experimental therapeutics 20040901

Title: Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery.

Journal: American journal of physiology. Heart and circulatory physiology 20040801

Title: Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.

Journal: Current eye research 20040701

Title: Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.

Journal: Mutation research 20040414

Title: Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.

Journal: Diabetologia 20040401

Title: PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation.

Journal: International journal of radiation oncology, biology, physics 20040201

Title: Role of the activation of the nuclear enzyme poly(ADP-ribose) polymerase in the pathogenesis of periodontitis.

Journal: Journal of dental research 20031201

Title: Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes.

Journal: Diabetes 20030701

Title: Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.

Journal: Shock (Augusta, Ga.) 20030501

Title: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock.

Journal: Biochemical pharmacology 20030415

Title: Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents.

Journal: Biochemical pharmacology 20021215

Title: Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.

Journal: Journal of the American College of Cardiology 20020904

Title: Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis.

Journal: Critical care medicine 20020501

Title: Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.

Journal: Critical care medicine 20020501

Title: Development of novel, water-soluble inhibitors of poly (adenosine 5'-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury.

Journal: Critical care medicine 20020501

Title: Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.

Journal: The Journal of pharmacology and experimental therapeutics 20020301

Title: Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation.

Journal: British journal of pharmacology 20020301

Title: Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.

Journal: The Annals of thoracic surgery 20020201

Title: Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.

Journal: Circulation research 20020111

Title: Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20011101

Title: Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.

Journal: Circulation research 20011012

Title: Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.

Journal: International journal of molecular medicine 20010301

Title: Iwashita A, et al. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2--(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Ph

Title: Haddad M, et al. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol. 2006 Sep;149(1):23-30.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 344458-19-1
Tags:344458-19-1 Molecular Formula|344458-19-1 MDL|344458-19-1 SMILES|344458-19-1 PJ34